QID 50123

Date Published: 2022-11-09

QID 50123: Microsoft Exchange Server Multiple Vulnerabilities for November 2022

Microsoft Exchange Server 2013, 2016 and 2019 are affected by multiple vulnerabilities.

This QID covers detection for the following vulnerabilities:
Microsoft Exchange Server Elevation of Privilege Vulnerability (CVE-2022-41080).
Microsoft Exchange Server Spoofing Vulnerability (CVE-2022-41079).
Microsoft Exchange Server Elevation of Privilege Vulnerability (CVE-2022-41123).

Microsoft Exchange Server Spoofing Vulnerability (CVE-2022-41078).

KB Articles associated with this update are: KB5019758

Affected Versions:
Microsoft Exchange Server 2013 Cumulative Update 23
Microsoft Exchange Server 2016 Cumulative Update 22
Microsoft Exchange Server 2016 Cumulative Update 23
Microsoft Exchange Server 2019 Cumulative Update 11
Microsoft Exchange Server 2019 Cumulative Update 12

QID Detection Logic (Authenticated):
The QID checks for vulnerable version of Microsoft Exchange Server by checking the file version of Exsetup.exe.

Successful exploitation of the vulnerability may allow spoofing attacks and privilege escalation.

CVSS V3 rated as Critical - 9.8 severity.

CVSS V2 rated as Critical - 10 severity.

Solution

Microsoft has released patch, customers are advised to refer to KB5019758 for information pertaining to this vulnerability.

Vendor References

CVE-2022-41078 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2022-41078
CVE-2022-41079 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2022-41079
CVE-2022-41080 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2022-41080
CVE-2022-41123 - msrc.microsoft.com/update-guide/en-US/vulnerability/CVE-2022-41123

CVEs related to QID 50123

CVE-2022-41080 | CVE-2022-41079 | CVE-2022-41123 | CVE-2022-41078 |

Software Advisories

Advisory ID	Software	Component	Link
5019758			support.microsoft.com/help/5019758

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].